title: Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.
abstract: The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems.
authors.affiliation: Department of Human Genetics, Sri Ramachandra University, Porur, India.
authors.forename: Ramya
authors.initials: R
authors.lastname: Ranganathan
authors.forename: Shruthilaya
authors.initials: S
authors.lastname: Madanmohan
authors.forename: Akila
authors.initials: A
authors.lastname: Kesavan
authors.forename: Ganga
authors.initials: G
authors.lastname: Baskar
authors.forename: Yoganathan Ramia
authors.initials: YR
authors.lastname: Krishnamoorthy
authors.forename: Roy
authors.initials: R
authors.lastname: Santosham
authors.forename: D
authors.initials: D
authors.lastname: Ponraju
authors.forename: Suresh Kumar
authors.initials: SK
authors.lastname: Rayala
authors.forename: Ganesh
authors.initials: G
authors.lastname: Venkatraman
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D050997:Nanomedicine / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy*